Like GE and Picker, Siemens Medical Systems (Hall B, #6726) introduced new short-bore MRI magnets in 1997. The Iselin, NJ, company calls its 1.5-tesla scanner Symphony, while its 1-tesla offering is known as Harmony. The superconducting magnets featured
Like GE and Picker, Siemens Medical Systems (Hall B, #6726) introduced new short-bore MRI magnets in 1997. The Iselin, NJ, company calls its 1.5-tesla scanner Symphony, while its 1-tesla offering is known as Harmony. The superconducting magnets featured on the scanners are slightly over 5 ft long and can been sited in suites as small as 325 sq ft. The 1.5-tesla and 1-tesla configurations weigh 8900 and 7700 lb, respectively.
In the nuclear medicine domain, Siemens will display a single-head version of its E.Cam variable-angle dual-head gamma camera, while the company's ultrasound business unit will debut Sonoline Versa Plus, a new version of its mid-range scanner.
In mammography, Mammomat 3000 will be displayed with the Opdima digital spot option, which received FDA clearance in May. In conventional x-ray, Fluorospot T.O.P. is the company's newest digital imaging upgrade for radiography/fluoroscopy applications and features a 2048 matrix. Multix T.O.P. is a new radiographic system, while Multistar Plus is new operating software for the company's Multistar angiography suite.
Megalix CAT is a new x-ray tube technology for angiography systems based on continuous accelerated anode technology, a liquid bearing design that Siemens believes will confer cost savings through longer tube life. Finally, Angiostar Plus is the company's newest angiography system, consisting of a floor-mounted C-arm for low-cost installation.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.